Ono Pharmaceutical Co., Ltd. (OPHLF)
OTCMKTS
· Delayed Price · Currency is USD
10.73
0.00 (0.00%)
May 14, 2025, 4:00 PM EDT
Ono Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 14, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Market Capitalization | 4,807 | 5,026 | 7,622 | 10,154 | 12,458 | 13,043 | Upgrade
|
Market Cap Growth | -34.06% | -34.06% | -24.93% | -18.50% | -4.48% | 13.11% | Upgrade
|
Enterprise Value | 4,419 | 4,953 | 7,043 | 9,448 | 12,065 | 12,357 | Upgrade
|
Last Close Price | 10.73 | 11.19 | 16.32 | 20.57 | 25.43 | 29.14 | Upgrade
|
PE Ratio | 14.38 | 15.04 | 9.01 | 11.97 | 18.79 | 19.13 | Upgrade
|
PS Ratio | 1.48 | 1.55 | 2.29 | 3.02 | 4.19 | 4.66 | Upgrade
|
PB Ratio | 0.91 | 0.96 | 1.44 | 1.81 | 2.29 | 2.25 | Upgrade
|
P/TBV Ratio | 1.67 | 1.75 | 1.57 | 2.01 | 2.56 | 2.55 | Upgrade
|
P/FCF Ratio | 9.34 | 9.77 | 10.81 | 8.75 | 26.86 | 21.54 | Upgrade
|
P/OCF Ratio | 8.73 | 9.13 | 10.42 | 8.46 | 24.47 | 19.50 | Upgrade
|
EV/Sales Ratio | 1.32 | 1.52 | 2.12 | 2.81 | 4.05 | 4.42 | Upgrade
|
EV/EBITDA Ratio | 7.15 | 8.24 | 5.97 | 7.50 | 11.40 | 11.93 | Upgrade
|
EV/EBIT Ratio | 10.19 | 11.75 | 6.65 | 8.37 | 13.22 | 13.84 | Upgrade
|
EV/FCF Ratio | 8.59 | 9.63 | 9.99 | 8.14 | 26.01 | 20.41 | Upgrade
|
Debt / Equity Ratio | 0.19 | 0.19 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 1.63 | 1.63 | 0.05 | 0.05 | 0.07 | 0.08 | Upgrade
|
Debt / FCF Ratio | 1.90 | 1.90 | 0.08 | 0.06 | 0.16 | 0.14 | Upgrade
|
Asset Turnover | 0.49 | 0.49 | 0.56 | 0.55 | 0.49 | 0.44 | Upgrade
|
Inventory Turnover | 2.40 | 2.40 | 2.72 | 2.54 | 2.31 | 2.38 | Upgrade
|
Quick Ratio | 2.32 | 2.32 | 2.92 | 1.71 | 2.56 | 1.58 | Upgrade
|
Current Ratio | 3.07 | 3.07 | 3.99 | 2.81 | 4.27 | 2.64 | Upgrade
|
Return on Equity (ROE) | - | - | 16.56% | 16.02% | 12.39% | 12.49% | Upgrade
|
Return on Assets (ROA) | - | - | 11.16% | 11.57% | 9.32% | 8.69% | Upgrade
|
Return on Capital (ROIC) | - | - | 12.81% | 13.14% | 10.49% | 10.06% | Upgrade
|
Return on Capital Employed (ROCE) | 6.90% | 6.90% | 19.80% | 19.80% | 16.50% | 15.10% | Upgrade
|
Earnings Yield | 6.95% | 6.65% | 11.10% | 8.35% | 5.32% | 5.23% | Upgrade
|
FCF Yield | 10.70% | 10.23% | 9.25% | 11.43% | 3.72% | 4.64% | Upgrade
|
Dividend Yield | 5.09% | 4.78% | 3.24% | 2.56% | 1.81% | 1.55% | Upgrade
|
Payout Ratio | 74.96% | 74.96% | 29.05% | 26.38% | 34.36% | 29.76% | Upgrade
|
Buyback Yield / Dilution | 2.14% | 2.14% | 1.70% | 1.65% | 0.54% | 0.96% | Upgrade
|
Total Shareholder Return | 7.23% | 6.92% | 4.94% | 4.21% | 2.35% | 2.51% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.